Chemo Drug Taxol Shortage Puts Cancer Patients at Risk

A shortage of Taxol, an intravenous chemotherapy workhorse for ovarian, breast, lung and colon cancers, demonstrates once again how vulnerable U.S. hospitals and clinics are to an increasingly unreliable pharmaceutical supply chain, leaving patients at risk. Paclitaxel, the generic version of Taxol, joins 196 other drugs on a shortage list compiled by the American Society of Health-System Pharmacists in Bethesda, Md. Although no one has been able to quantify the number of lives jeopardized...Full Story
Commenting on this article is closed.